These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3626043)

  • 21. Immunological definition of leukemic cell surface phenotypes.
    Melvin SL
    Cancer Res; 1981 Nov; 41(11 Pt 2):4790-3. PubMed ID: 6975161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Surface marker analysis with monoclonal antibodies in childhood acute lymphocytic leukemia].
    Kawai S; Fujimoto T; Yatabe M; Utsumi J; Mimaya J; Sekine I; Okada T; Smike S; Koizumi S; Imashuku S
    Rinsho Ketsueki; 1984 Aug; 25(8):1209-17. PubMed ID: 6334758
    [No Abstract]   [Full Text] [Related]  

  • 23. Acute lymphoblastic leukemia with Burkitt's lymphoma cells: membrane markers and serum immunoglobulin.
    Preud'homme JL; Brouet JC; Danon F; Flandrin G; Schaison G
    J Natl Cancer Inst; 1981 Feb; 66(2):261-4. PubMed ID: 6779044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of surface antigens using the Coulter counter: a simple highly sensitive method.
    Attallah AM; Yeatman TJ
    Diagn Immunol; 1983; 1(1):39-42. PubMed ID: 6594208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production of colony-stimulating activity (CSA) by T-chronic lymphocytic leukemia cells.
    Douer D; Ben-Bassat I; Shaked N; Ramot B
    Isr J Med Sci; 1985 Aug; 21(8):656-61. PubMed ID: 3876320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunophenotyping in leukaemias is not a luxury.
    Kurukulasuriya AP; Wijesiriwardene B; Perera TK
    Ceylon Med J; 1998 Jun; 43(2):117-8. PubMed ID: 9704557
    [No Abstract]   [Full Text] [Related]  

  • 27. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Surface marker studies on lymphoma and leukemia cells with microcytotoxicity test using the UCLA Monoclonal Antibody Tray 5].
    Toki H; Okabe K; Kimura Y; Fujii M; Tamai M; Moriwaki S; Yamamoto Y
    Gan No Rinsho; 1985 Apr; 31(4):409-13. PubMed ID: 3874297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a model of chronic lymphocytic leukemia in inbred strain 2 guinea pigs.
    Key ME; Brandhorst JS; Bucana CD; Hanna MG
    J Natl Cancer Inst; 1983 Jun; 70(6):1139-49. PubMed ID: 6574284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitation of surface-membrane and intracellular gamma, mu and kappa chains of normal and neoplastic human lymphocytes.
    Cooper AG; Brown MC; Derby HA; Wortis HH
    Clin Exp Immunol; 1973 Apr; 13(4):487-96. PubMed ID: 4717093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-ATLA (antibody to adult T-cell leukemia virus-associated antigen), highly positive in OKT4-positive mature T-cell malignancies.
    Tobinai K; Nagai M; Setoya T; Shibata T; Minato K; Shimoyama M
    Jpn J Clin Oncol; 1983; 13 Suppl 2():237-44. PubMed ID: 6603532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Membrane markers in chronic lymphoproliferative diseases].
    Matutes E; San Miguel JF; Catovsky D
    Med Clin (Barc); 1983 Mar; 80(7):334-50. PubMed ID: 6406774
    [No Abstract]   [Full Text] [Related]  

  • 33. Laboratory, morphologic, and immunophenotypic correlates of surface immunoglobulin heavy chain isotype expression in B-cell chronic lymphocytic leukemia.
    Shen PU; Fuller SG; Rezuke WN; Sherburne BJ; DiGiuseppe JA
    Am J Clin Pathol; 2001 Dec; 116(6):905-12. PubMed ID: 11764081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of aggregated IgG by lymphocytes in chronic lymphocytic leukemia.
    Augener W; Cohnen G; Brittinger G
    Biomedicine; 1974 Jan; 21(1):6-8. PubMed ID: 4602945
    [No Abstract]   [Full Text] [Related]  

  • 35. Study of cell-surface markers in chronic lymphocytic leukaemia (CLL).
    Rak K; Pecze K; Kiss A; Telek B
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(3):294-300. PubMed ID: 6205953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of number of HLA determinants in HLA capping in childhood acute lymphoblastic leukemia.
    Hogeman PH; Veerman AJ; Philippus E; Huismans DR; van Zantwijk CH; Bezemer PD
    Acta Haematol; 1985; 73(4):196-200. PubMed ID: 2414955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA & surface markers in untreated lymphoid leukaemia patients.
    Mehta MM; Contractor NM; Advani SH; Bhatia HM
    Indian J Med Res; 1987 Apr; 85():415-9. PubMed ID: 3623651
    [No Abstract]   [Full Text] [Related]  

  • 38. Lymphocyte populations with 5'-nucleotidase in chronic lymphocytic leukemia.
    Kanter RJ; Freiberger IA; Rai KR; Sawitsky A
    Clin Immunol Immunopathol; 1979 Mar; 12(3):351-7. PubMed ID: 455790
    [No Abstract]   [Full Text] [Related]  

  • 39. B-CLL with surface IgM kappa phenotype.
    Chapman CS; Gooch ME; Shaw DE; Campbell AC
    Br J Haematol; 1987 Nov; 67(3):375-6. PubMed ID: 3500739
    [No Abstract]   [Full Text] [Related]  

  • 40. Detergent binding of human membrane immunoglobulin M.
    McIlhinney RA
    Mol Immunol; 1980 Aug; 17(8):1083-6. PubMed ID: 7442684
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.